Logo

American Heart Association

  167
  0


Final ID:

Discussant: CLEAR SYNERGY

  • Bonaca, Marc  ( CPC Clinical Research , Aurora , Colorado , United States )
  • Author Disclosures:
    Marc Bonaca: DO have relevant financial relationships ; Research Funding (PI or named investigator):Dr. Bonaca is the Executive Director of CPC:Active (exists now) ; Research Funding (PI or named investigator):Dr. Bonaca is the Executive Director of CPC:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

From Intervention to Prevention: Advances in Coronary and Valvular Heart Disease

Sunday, 11/17/2024 , 08:00AM - 09:15AM

Late-Breaking Science

More abstracts on this topic:
Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early after Surgical Bioprosthetic Valve Replacement: ENBALV trial

Izumi Chisato, Amano Masashi, Fukushima Satsuki, Yaku Hitoshi, Eishi Kiyoyuki, Sakaguchi Taichi, Minami Manabu, Yamamoto Haruko, Omae Katsuhiro

Discussant: ENBALV

Windecker Stephan, Steg Philippe

You have to be authorized to contact abstract author. Please, Login
Not Available